Document is current
Any future updates will be listed below
-
Authors
Kulkarni, C.
Fardeen, T. https://orcid.org/0000-0001-6050-740X
Gubatan, J. https://orcid.org/0000-0001-6037-2883
Ye, J.
Jarr, K.
Dickson, E.
Jang, H. https://orcid.org/0009-0001-4124-9908
Temby, M.
Patel, A.
Jiang, Y.
Singh, G.
Keyashian, K.
Streett, S.
Ho, E.
Barber, G.
Singh, S.
Limsui, D.
Anaizi, N.
Becker, L. https://orcid.org/0000-0002-8736-0257
Spencer, S. P. https://orcid.org/0000-0002-7328-5399
Mehrish, D.
Perelman, D. https://orcid.org/0000-0003-3335-1950
Longo, V. D. https://orcid.org/0000-0002-0946-7534
Charu, V.
Ashouri, J. F. https://orcid.org/0000-0001-8405-7503
Davis, M. M. https://orcid.org/0000-0001-6868-657X
Habtezion, A.
Sonnenburg, J. L.
Gardner, C. https://orcid.org/0000-0002-7596-1530
Sinha, S. R. https://orcid.org/0000-0001-5104-6410
- License Information
-
More Information
Article History
Received: 11 June 2025
Accepted: 10 December 2025
First Online: 13 January 2026
Competing interests
: V.D.L. has equity interest in L-Nutra and has filed patents related to the FMD. V.D.L. does not receive consulting fees from L-Nutra and has committed his shares of the company to charitable organizations. The authors declare no competing interests.
